CAS NO: | 6028-00-8 |
包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
1 g | 电议 |
Cas No. | 6028-00-8 |
别名 | 骆驼蓬酚盐酸盐(二水) |
Canonical SMILES | OC1=CC=C2C(NC3=C2CCN=C3C)=C1.Cl.O.O |
分子式 | C12H12N2O • HCl [2H2O] |
分子量 | 272.7 |
溶解度 | DMF: 10 mg/ml,DMSO: 1 mg/ml,Ethanol: 2 mg/ml,PBS (pH 7.2): insol |
储存条件 | -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | Harmalol is a β-carboline alkaloid and an active metabolite of harmaline that has been found inP. harmalaand has diverse biological activities.1,2,3,4,5It is an inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A; IC50= 0.63 µM) and monoamine oxidase A (MAO-A; IC50= 0.66 µM).3It is selective for DYRK1A over Cdk1, Cdk5, CK1α1, Clk4, DYRK2, Pim-1, and GSK3β but also inhibits DYRK1B and Clk1 at 10 µM. It inhibits proliferation of H4 human glioblastoma cells (IC50s = 23.7 µM). Harmalol (0.5-12.5 µM) reduces increases in the levels of the cytochrome P450 (CYP) isoform CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells and prevents TCDD-induced activation of the aryl hydrocarbon receptor (AhR) in guinea pig hepatic cytosolic extracts.4It reduces glutamate-induced cytotoxicity, cytochromecrelease, caspase-3 activation, and the production of reactive oxygen species (ROS) in PC12 cells when used at a concentration of 25 µM.5This product is also available as an analytical reference standard . 1.Brierley, D.I., and Davidson, C.Developments in harmine pharmacology - implications for ayahuasca use and drug-dependence treatmentProg. Neuropsychopharmacol. Biol. Psychiatry39(2)263-272(2012) 2.Nikam, T.D., Nitnaware, K.M., and Ahire, M.L.Alkaloids derived from tryptophan: Harmine and related alkaloidsNatural products. Phytochemistry, botany and metabolism of alkaloids, phenolics and terpenes553-574(2013) 3.Tarpley, M., Oladapo, H.O., Strepay, D., et al.Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studiesEur. J. Pharm. Sci.162105821(2021) 4.El Gendy, M.A.M., Soshilov, A.A., Denison, M.S., et al.Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanismsFood Chem. Toxicol.50(2)353-362(2012) 5.Han, E.S., and Lee, C.S.Inhibition of glutamate-induced change in mitochondrial membrane permeability in PC12 cells by 1-methylated β-carbolinesBiomol. Ther. (Seoul)11(2)112-118(2003) |